相关实验视频

Updated: May 7, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

韩国免疫实践专家委员会的结构,作用和程序

So Yun Lim¹, Han Wool Kim², Young June Choe³

¹Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

|January 6, 2025

概括

韩国免疫实践专家委员会 (KECIP) 指导韩国的疫苗政策. 本综述详细介绍了KECIP在公共卫生和传染病控制方面的历史,运作和成就.

科学领域:

公共卫生公共卫生
免疫学免疫学免疫学
流行病学流行病学

背景情况:

疫苗接种对于预防传染病和改善全球卫生结果至关重要.
韩国免疫实践专家委员会 (KECIP) 是韩国国家免疫战略的核心.
了解KECIP的作用是欣赏国家在疾病预防方面的成功的关键.

研究的目的:

对韩国免疫实践专家委员会 (KECIP) 进行全面审查.
调查KECIP的历史,法律框架,运营结构和主要成就.
突出KECIP对韩国成功的疫苗接种计划和公共卫生的影响.

主要方法:

文献综述和对KECIP历史文件和运营数据的分析.
检查KECIP的审议过程,标准设定和疾病管理策略.
评估KECIP的结构组织,包括小组委员会和道德准则.

主要成果:

KECIP表现出一个明确的结构,专门的小组委员会和强大的道德协议.
该委员会在扩大疫苗覆盖率和优化不同人群的疫苗接种计划方面发挥了重要作用.
KECIP成功管理了针对性的传染病,并为国家根除战略做出了贡献.

结论:

在韩国公共卫生基础设施中,KECIP发挥着关键作用,为疫苗接种成果做出了重大贡献.
该委员会的战略发展和对科学严谨性的承诺确保了有效的传染病控制.
KECIP的综合方法优化了基础疫苗接种,并支持特殊人群,提高了整体公共卫生.

关键词:

免疫政策免疫政策韩国免疫实践专家委员会国家疫苗接种计划

更多相关视频

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

相关概念视频

Vaccinations

Vaccinations

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...

International Nursing Organizations I

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...